Agaris™ is the proprietary commercial brand of premium agarwood (Aquilaria malaccensis) tissue-cultured plantlets developed and produced by Crown Organogenesis Protocols Inc. (COPI).
It represents a scientifically propagated, genetically uniform, and disease-screened line of planting materials engineered for high-performance agarwood plantations.
Etymological Meaning
Agaris™ is derived from:
- “Agar” – referencing agarwood (oud), the high-value resinous heartwood.
- “-is” – a suffix implying origin, growth, and identity.
Together, Agaris™ signifies:
“The Origin of Premium Agarwood.”
Technical Definition
Agaris™ Plantlets are laboratory-propagated agarwood clones produced via advanced organogenesis and tissue culture protocols to ensure:
- Genetic uniformity
- High vigor and survival rate
- Pathogen-free propagation
- Scalable plantation deployment
- Predictable growth performance
Unlike conventional seedlings, Agaris™ plantlets are developed under controlled sterile conditions, making them suitable for commercial-scale agroforestry and investment-grade plantations.
Brand-Level Definition
Agaris™ is biotech precision for premium agarwood cultivation — uniform, vigorous, and plantation-ready plantlets grown from laboratory to land.